InvestorsHub Logo
Followers 30
Posts 2774
Boards Moderated 4
Alias Born 10/24/2015

Re: None

Tuesday, 10/02/2018 11:50:43 AM

Tuesday, October 02, 2018 11:50:43 AM

Post# of 108
$JNJ has terminated the exclusive global license agreement to develop ADU-214, ADU-741 and GVAX Prostate for all indications. From the wording I don't hold out much hope for pLADD.

https://www.sec.gov/Archives/edgar/data/1435049/000119312518289503/d619516d8k.htm